Dr. Jonathan Jay Melquist, MD

Dr. Melquist practices at Baptist Medical Center Jacksonville in Jacksonville, Florida, part of Baptist Health.

Dr. Melquist's NPI, 1336396910, was assigned on August 26, 2008. Dr. Melquist graduated from University Of Minnesota Medical School in 2007. Dr. Melquist holds Florida license ME123683.

Dr. Melquist's primary practice is Baptist Medical Center Jacksonville, at 800 Prudential Dr, Jacksonville, FL 32207 in Duval County. The practice phone is (904) 202-2000.

Dr. Melquist's primary practice is Baptist Medical Center Jacksonville in Jacksonville, Florida, part of Baptist Health. Dr. Melquist is also affiliated with Baptist Medical Center Beaches. The medical group on file is Baptist MD Anderson Cancer Physicians. Dmand AI also links Dr. Melquist to 1 more hospital, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Melquist practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Melquist's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Melquist is board certified in urology by the American Board of Urology. Dmand AI has Dr. Melquist's licenses on file in 3 states: Florida, Georgia and Texas.

Dmand AI lists bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney disease, kidney removal surgery and kidney stone disease among the conditions Dr. Melquist treats.

CMS data shows 724 Medicare services from Dr. Melquist across 16 procedure codes in 2024, for 360 Medicare patients. Medicare paid $79,070 for them.

CMS counts 360 Medicare patients who saw Dr. Melquist in 2024. The largest group is 65 to 74, with 162 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Melquist's median patient age at 74, with 22% women.

In 2024, Dr. Melquist wrote 296 Medicare Part D claims for 119 patients. 96% of them were for generic drugs. CMS names the drug for 233 of them, across 5 drugs with 11 or more claims each, at $8,284 in total drug cost. In 2023, CMS named 246 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Melquist for performance year 2024, reported as part of a group. Dr. Melquist accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Melquist as offering telehealth. CMS counts 23 procedures of prostate resection by Dr. Melquist, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 15 papers to Dr. Melquist, published from 2008 to 2020. 2015 was the busiest year, with 3. The most frequent topics are Urinary Bladder Neoplasms and Cell Line, Tumor. Dr. Melquist has published most often in Urol Oncol. Dr. Melquist's most frequent co-authors are Colin P. Dinney, MD, Sima Prabodh Porten, MD and Scott E. Delacroix, MD.

CMS Open Payments shows 229 general payments to Dr. Melquist from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 50% of the total. Intuitive Surgical, Inc. paid the most, $6,207.

Dr. Melquist graduated from University Of Minnesota Medical School in 2007.

Dr. Melquist is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.